Pharmaceutical Regulatory Affairs: Open Access (PRA)

Journal of Pharmaceutical Regulatory Affairs represents one of the leading International online platforms for communication and exchange of scholarly information on the current and prevailing laws and the regulatory concepts as applicable to the development and commercialization of pharmaceutical & biomedical products; food; beverages; biotech products and cosmetics originating from across the world. The journal publishes peer-reviewed articles under open access creative commons attribution license terms and are of immense relevance to the pharmacy students, physicians, clinicians, pharmaceutical & biopharmaceutical industrialists, regulatory affair professionals, manufacturers of medical devices and equipment, practicing attorneys, regulators, as well as academic and research community engaged in the designing and development of new drugs. The journal offers wide coverage of topics including trends and guidelines of various National and International regulatory agencies, Pharmacovigilance, new drug application processes, protocols of achieving regulatory compliance, legislative revisions, regulatory approvals, marketing practices, as well as the formulation & streamlining of good manufacturing practice. The journal’s core focus is on the procedures, protocols, standards & policies, pharmaceutical regulations, quality control and quality assurance of drug development.

Pharmaceutical Regulatory Affairs: Open Access (PRA) is :-

• International, Peer-Reviewed, Open Access, Refereed, Pharmaceutical Regulatory Affairs, Drug Development, Pharmacovigilance, Regulatory Science, Pharmaceutical Policy, Quality Assurance, Good Manufacturing Practices, Biopharmaceutical Regulation, Medical Device Regulation , Online , Bi-Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN E-ISSN: 2167-7689, Established: 2012, Impact Factor: 2.15
• Provides Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE